soul trial oral semaglutide cardiovascular outcomes 2024 results shows has positive CV benefits in type 2 diabetes Novo Nordisk Positive Results from

A pragmatic, research aligned approach is to start at one gram daily and, if tolerated, move toward two grams per day

A 70mg Glow formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications

The difference between clinical and practical dosing Clinical trials operated under controlled conditions that do not reflect real-world use

Oncotarget 6(23):1946919482

at high doses, it overwhelms and glucuronidation/CYP2E1 take over) Bile acids Catecholamines (dopamine, norepinephrine, epinephrine) Cholesterol DHEA and steroid hormones Estrogens Minoxidil (requires sulfation for activation) Thyroid hormones Sulfation is not always detoxifying